This content is machine translated Autoimmune hemolytic anemia Keep calm! Autoimmune hemolytic anemia (AIHA) is caused by autoantibodies with and without complement activation. The risk of thromboembolic complications is often increased. In heat-type AIHA, corticosteroids are considered first-line therapy; in…
View Post 3 min This content is machine translated Endometrial Cancer Prolonged progression-free survival through combination therapy Endometrial cancer is the sixth most common cancer in women worldwide and has a poor prognosis, particularly in terms of long-term results. The median overall survival time is less than…
View Post 7 min This content is machine translated Dermatomyositis Diagnostics and treatment – a current overview Pathognomonic skin signs of dermatomyositis include heliotrope erythema, Gottron papules, and Gottron signs. The determination of myositis-specific autoantibodies has an increasingly important role in the diagnosis. Regarding treatment options, intravenous…
View Post 4 min This content is machine translated Bullous pemphigoid Updated European expert guideline published The Autoimmune blistering diseases Task Force of the European Academy of Dermatology and Venereology (EADV) recently issued new recommendations for the treatment of bullous pemphigoid. The consensus expert opinion is based…
View Post 7 min This content is machine translated Lupus nephritis Special case kidney For a long time, the treatment of lupus was characterized by stagnation. However, after 20 years of frustration, there is finally movement to develop new therapeutic options. Studies have produced promising results…
View Post 5 min This content is machine translated COVID-19 and rheumatism Do not discontinue immunosuppressants! The SARS-CoV-2 pandemic poses special challenges for physicians and patients – even more so if the latter have pre-existing conditions and are on immunosuppressive drugs. Researchers have explored the question…
View Post 9 min This content is machine translated Multiple Sclerosis (MS) News on monoclonal antibody therapy A widespread chronic disease, affecting a majority of young adults, causes a vehement financial and societal interest to develop effective and tolerable therapies. In 2017 alone, two new monoclonal antibodies…
View Post 2 min This content is machine translated Chronic Fatigue Syndrome Hope through rituximab? Purpose: Does immunomodulatory therapy with rituximab (Mabthera®) lead to sustained symptom improvement in patients suffering from chronic fatigue syndrome (CFS)?
View Post 7 min This content is machine translated 57th ASH Meeting in Orlando New field of application for rituximab The ASH Congress was held last year in Orlando. This time, one of the topics was the efficacy of rituximab in adult patients with B-precursor acute lymphoblastic leukemia (ALL). Up…
View Post 8 min This content is machine translated Rituximab, eculizumab, eprodisate New treatment options for glomerular diseases Glomerular diseases are important causes of end-stage renal failure. Pathogenetically, immune-mediated processes are in the foreground. Thanks to advancing knowledge of the pathophysiology and modern genetic engineering methods, there is…
View Post 6 min This content is machine translated Medidays: Update Hematology Anemia, new anticoagulants, and CLL. At Medidays, the internal medicine training program of the University Hospital Zurich (USZ), presentations were also given on various hematology topics. How is anemia meaningfully clarified? Which patients should be…
